Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	112.37	45.66	21.50
Graham Fair Price	-19.52	4.36	5.42
PEG	291.80	-0.46	0.12
Price/Book	19.56	2.50	2.09
Price/Cash Flow	inf	0.00	17.19
Prices/Earnings	86.57	16.28	8.72
Price/Sales	170.73	6.12	2.26
Price/FCF	inf	0.00	17.19
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	162.91	0.41	0.16
Operating Margin	13.13	0.07	0.06
ROA	inf	0.00	0.03
ROE	0.06	0.04	-35.92
ROIC	0.03	0.02	-38.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	0.68	-96.13
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.67	-0.50	-24.78
EPS QOQ	0.75	-0.36	-52.38
FCF QOQ	0.00	-1.00	-100.00
Revenue QOQ	1.35	-0.56	-58.70
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	64.61	0.00	inf
Days Sales Outstanding (DSO)	53.83	0.00	inf
Inventory Turnover	1.39	0.00	inf
Debt/Capitalization	0.16	0.05	-71.96
Quick Ratio	1.20	0.00	inf
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.67	4.69	0.54
Cash	1.68	5.03	198.79
Capex	-0.05	0.00	inf
Free Cash Flow	0.57	0.00	inf
Revenue	4.31	1.91	-55.60
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.94	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.70	-3.11	-83.34
Naive Interpretation	Member

06 - Financial Health · Bad

Rating